NFKB1 and neoplasm: NF-κB can be activated by a variety of stimulants, such as lipopolysaccharide (LPS), inflammatory stimuli, cytokines, tumor promoters, and two kinase-dependent pathways: the canonical and non-canonical NF-κB pathway.